SB 201-1_ Filed 01/25/2012, 11:42 ChairPerson

COMMITTEE REPORT




MADAM PRESIDENT:

    The Senate Committee on Health and Provider Services, to which was referred Senate Bill No. 201, has had the same under consideration and begs leave to report the same back to the Senate with the recommendation that said bill be AMENDED as follows:

SOURCE: Page 1, line 1; (12)AM020101.1. -->     Page 1, between the enacting clause and line 1, begin a new paragraph and insert:
SOURCE: IC 16-18-2-128.5; (12)AM020101.1. -->     "SECTION 1. IC 16-18-2-128.5, AS ADDED BY P.L.126-2005, SECTION 3, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE JULY 1, 2012]: Sec. 128.5. (a) "Fetal stem cell" means any of the following types of stem cells taken from a fetus that was either miscarried or stillborn from any of the following sources:
        (1) Placenta.
        (2) Umbilical cord.
        (3) Amniotic fluid.
        (4) Fetal tissue.
    (b) The term does not include any cells that are taken as the result of an abortion. unless the cells are permissible for use under applicable federal law.".
SOURCE: Page 2, line 12; (12)AM020101.2. -->     Page 2, line 12, delete "," and insert " (as defined in IC 16-18-2-128.5),".
    Page 2, after line 13, begin a new paragraph and insert:
    " (d) Any person who recklessly, knowingly, or intentionally uses a human embryo created with an ovum provided to a qualified third party under this section for purposes of embryonic stem cell research commits unlawful use of an embryo, a Class C felony.".
    Renumber all SECTIONS consecutively.
    (Reference is to SB 201 as introduced.)

and when so amended that said bill do pass .

Committee Vote: Yeas 7, Nays 0.

____________________________________

Senator Miller, Chairperson


AM 020101/DI 97    2012